Composition for ophthalmic use containing sepetaprost
AssigneesSanten Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd.
InventorsYoko ENDO, Sachie NAKAYAMA, Kenji MASAKI, Kenta YOSHII, Tadahiro MAEIE, Seiichi TANIKAWA
Life of this patent
Estimating the term…
Abstract
A method for stabilizing a composition for ophthalmic use containing sepetaprost is disclosed. More specifically, a method that facilitates retention of sepetaprost stability at high temperatures, and further, a method that facilitates the retention of preservative effectiveness of the composition for ophthalmic use are disclosed. The composition for ophthalmic use contains sepetaprost at a concentration of 0.0001 to 0.003% (w/v) and has a pH within a range from 5 to 8.
Claims38
An ophthalmic composition comprising sepetaprost at a concentration of 0.0001 to 0.003% (w/v), wherein the pH of the composition is in a range of 5 to 8.
-21. (canceled)
-33. (canceled)
-38. (canceled)
-46. (canceled)
Dependencies are inferred from the claim text.